Cumberland Pharmaceuticals Inc

CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 326 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cumberland Pharmaceuticals Inc, Reports and events
Filed	Form	What it is	Accession number
2021-05-1417:14 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001628280-21-010387
2021-05-1117:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-009844
2021-04-3017:15 ET	8-K	5.07 Shareholder vote results	0001628280-21-008486
2021-03-1517:01 ET	DEF 14A	Proxy statementPeriod 2021-04-27	0001628280-21-004751
2021-03-1217:17 ET	10-K	Annual reportPeriod 2020-12-31	0001628280-21-004654
2021-03-0917:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-21-004286
2020-12-1017:18 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001628280-20-017370
2020-11-1317:16 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001628280-20-016446
2020-11-1017:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-016214
2020-10-0917:20 ET	8-K	1.01 Entry into a material agreement	0001628280-20-014431
2020-08-1417:08 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001628280-20-012738
2020-08-1117:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-012444
2020-07-2417:16 ET	10-Q/A	Quarterly report, amendedPeriod 2020-03-31	0001628280-20-010607
2020-05-2917:24 ET	8-K	8.01 Other events	0001628280-20-008691
2020-05-2217:13 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001628280-20-008312
2020-05-2017:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-20-008136
2020-05-0817:26 ET	8-K	8.01 Other events	0001628280-20-007253
2020-05-0817:25 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001628280-20-007252
2020-05-0117:16 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001628280-20-006158
2020-04-2117:13 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation	0001628280-20-005204
2020-03-2017:17 ET	DEF 14A	Proxy statementPeriod 2020-05-05	0001628280-20-003882
2020-03-2017:12 ET	10-K	Annual reportPeriod 2019-12-31	0001628280-20-003880
2020-03-1817:16 ET	8-K	2.02 Results of operations	0001628280-20-003774
2020-01-1017:29 ET	8-K	8.01 Other events	0001628280-20-000294
2020-01-0317:16 ET	8-K	2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits	0001628280-20-000118
2019-12-0617:17 ET	8-K	8.01 Other events	0001628280-19-014834
2019-11-2917:23 ET	8-K	8.01 Other events	0001628280-19-014611
2019-11-1317:19 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001628280-19-014133
2019-11-1217:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-19-014002
2019-10-1817:17 ET	8-K	8.01 Other events	0001628280-19-012420
2019-09-2717:16 ET	8-K	8.01 Other events	0001628280-19-011974
2019-09-2017:14 ET	8-K	5.02 Departure or appointment of officers or directors	0001628280-19-011867
2019-09-1117:16 ET	8-K	8.01 Other events	0001628280-19-011632
2019-09-1017:14 ET	8-K	8.01 Other events	0001628280-19-011597
2019-08-2317:02 ET	8-K	8.01 Other events	0001628280-19-011156
2019-08-1417:28 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001628280-19-010781
2019-08-1417:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-19-010778
2019-05-1517:12 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001628280-19-006841
2019-05-1417:25 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001628280-19-006756
2019-04-2617:29 ET	8-K	5.07 Shareholder vote results	0001628280-19-004839
2019-03-1417:21 ET	DEF 14A	Proxy statementPeriod 2019-04-23	0001628280-19-002966
2019-03-1219:12 ET	10-K	Annual reportPeriod 2018-12-31	0001628280-19-002785
2019-02-2617:11 ET	8-K	2.02 Results of operations	0001628280-19-001992
2019-01-2817:24 ET	8-K	8.01 Other events	0001628280-19-000602
2019-01-2820:21 ET	8-K/A	9.01 Financial statements and exhibits	0001628280-19-000571
2019-01-2417:30 ET	8-K	8.01 Other events	0001628280-19-000534
2019-01-1417:34 ET	8-K	8.01 Other events	0001628280-19-000288
2018-12-0717:13 ET	8-K	1.01 Entry into a material agreement	0001628280-18-014936
2018-11-1617:12 ET	8-K	2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits	0001628280-18-014467
2018-11-1417:16 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001628280-18-014380

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:05 ET. Listed shows no prices and gives no investment advice.